| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mouth Neoplasms | 17 | 2020 | 463 | 3.78 | Why? |
| Carcinoma, Squamous Cell | 23 | 2021 | 902 | 3.38 | Why? |
| Head and Neck Neoplasms | 22 | 2021 | 1568 | 2.65 | Why? |
| Neck Dissection | 6 | 2019 | 109 | 1.89 | Why? |
| Thyroid Neoplasms | 11 | 2019 | 422 | 1.62 | Why? |
| Hypopharyngeal Neoplasms | 2 | 2019 | 47 | 0.84 | Why? |
| Hyperparathyroidism | 1 | 2020 | 38 | 0.82 | Why? |
| Orbit Evisceration | 1 | 2018 | 3 | 0.76 | Why? |
| Orbital Neoplasms | 1 | 2018 | 27 | 0.72 | Why? |
| Paranasal Sinus Neoplasms | 1 | 2018 | 55 | 0.69 | Why? |
| DNA Methylation | 7 | 2019 | 688 | 0.67 | Why? |
| Cell Cycle Checkpoints | 1 | 2017 | 126 | 0.66 | Why? |
| Gene Expression Regulation, Neoplastic | 7 | 2018 | 1014 | 0.66 | Why? |
| Endoscopy | 3 | 2018 | 1564 | 0.66 | Why? |
| Tumor Suppressor Protein p53 | 5 | 2019 | 310 | 0.65 | Why? |
| Translations | 1 | 2017 | 153 | 0.63 | Why? |
| Disease-Free Survival | 12 | 2019 | 1654 | 0.61 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2020 | 1316 | 0.60 | Why? |
| Cell Cycle Proteins | 1 | 2018 | 297 | 0.60 | Why? |
| Elective Surgical Procedures | 4 | 2021 | 5338 | 0.59 | Why? |
| Lymphatic Metastasis | 5 | 2019 | 537 | 0.56 | Why? |
| Time-to-Treatment | 2 | 2021 | 5883 | 0.53 | Why? |
| Informed Consent | 1 | 2021 | 890 | 0.52 | Why? |
| National Health Programs | 1 | 2020 | 807 | 0.50 | Why? |
| Carcinoma, Papillary | 3 | 2017 | 76 | 0.48 | Why? |
| Thyroidectomy | 3 | 2019 | 207 | 0.47 | Why? |
| Biomarkers, Tumor | 9 | 2019 | 1314 | 0.46 | Why? |
| Neoplasm Recurrence, Local | 9 | 2019 | 1063 | 0.44 | Why? |
| Preoperative Care | 1 | 2020 | 1515 | 0.41 | Why? |
| Margins of Excision | 3 | 2019 | 122 | 0.40 | Why? |
| Receptor, ErbB-2 | 2 | 2017 | 267 | 0.40 | Why? |
| Lip Neoplasms | 2 | 2019 | 8 | 0.39 | Why? |
| Li-Fraumeni Syndrome | 2 | 2019 | 4 | 0.39 | Why? |
| ErbB Receptors | 2 | 2017 | 320 | 0.38 | Why? |
| Dendritic Cells | 1 | 2018 | 1330 | 0.38 | Why? |
| Robotic Surgical Procedures | 1 | 2017 | 787 | 0.37 | Why? |
| Postoperative Complications | 4 | 2021 | 5861 | 0.37 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 3 | 2020 | 9706 | 0.37 | Why? |
| Neoplasm Staging | 7 | 2019 | 1999 | 0.37 | Why? |
| Adenoma, Pleomorphic | 1 | 2008 | 10 | 0.37 | Why? |
| Microfilament Proteins | 2 | 2018 | 45 | 0.36 | Why? |
| Surgical Oncology | 3 | 2021 | 923 | 0.36 | Why? |
| Tongue Neoplasms | 2 | 2018 | 54 | 0.36 | Why? |
| Parotid Neoplasms | 1 | 2008 | 29 | 0.35 | Why? |
| Neoplasm Invasiveness | 6 | 2019 | 582 | 0.32 | Why? |
| Brazil | 11 | 2020 | 12582 | 0.31 | Why? |
| Otolaryngology | 1 | 2020 | 1917 | 0.30 | Why? |
| Patient Safety | 2 | 2020 | 4885 | 0.30 | Why? |
| Practice Guidelines as Topic | 5 | 2020 | 15421 | 0.29 | Why? |
| Oropharyngeal Neoplasms | 2 | 2007 | 138 | 0.29 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.28 | Why? |
| SEER Program | 1 | 2005 | 146 | 0.28 | Why? |
| Ki-67 Antigen | 2 | 2017 | 139 | 0.27 | Why? |
| Neoplasms | 4 | 2021 | 17251 | 0.27 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.26 | Why? |
| Germ-Line Mutation | 3 | 2019 | 86 | 0.26 | Why? |
| Medical Oncology | 1 | 2020 | 3826 | 0.26 | Why? |
| Neoplasm Proteins | 3 | 2018 | 501 | 0.26 | Why? |
| Kaplan-Meier Estimate | 5 | 2018 | 4260 | 0.25 | Why? |
| Developing Countries | 1 | 2019 | 4283 | 0.25 | Why? |
| Immunohistochemistry | 3 | 2018 | 2275 | 0.24 | Why? |
| Prognosis | 16 | 2019 | 32490 | 0.23 | Why? |
| Adenocarcinoma, Follicular | 2 | 2019 | 21 | 0.23 | Why? |
| Radionuclide Imaging | 1 | 2002 | 184 | 0.22 | Why? |
| Palatal Obturators | 1 | 2020 | 10 | 0.22 | Why? |
| Maxillofacial Prosthesis | 1 | 2020 | 11 | 0.22 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.21 | Why? |
| Stomatitis | 1 | 2020 | 57 | 0.21 | Why? |
| Phosphofructokinase-2 | 1 | 2019 | 2 | 0.20 | Why? |
| Trismus | 1 | 2019 | 6 | 0.20 | Why? |
| Recurrent Laryngeal Nerve Injuries | 1 | 2019 | 34 | 0.20 | Why? |
| Humans | 64 | 2021 | 930598 | 0.19 | Why? |
| Telomerase | 1 | 2019 | 45 | 0.19 | Why? |
| Hyaluronan Receptors | 1 | 2019 | 61 | 0.19 | Why? |
| Drainage | 1 | 2002 | 414 | 0.19 | Why? |
| Operative Time | 2 | 2020 | 450 | 0.19 | Why? |
| LIM Domain Proteins | 1 | 2018 | 8 | 0.19 | Why? |
| Epigenesis, Genetic | 4 | 2018 | 711 | 0.19 | Why? |
| Thyroid Nodule | 1 | 2019 | 70 | 0.18 | Why? |
| Aged | 30 | 2021 | 215776 | 0.18 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.18 | Why? |
| Antigens, CD1 | 1 | 2018 | 31 | 0.18 | Why? |
| Cathepsin K | 1 | 2017 | 8 | 0.18 | Why? |
| Tissue Array Analysis | 1 | 2018 | 75 | 0.18 | Why? |
| Muscle Proteins | 1 | 2018 | 64 | 0.18 | Why? |
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 20 | 0.18 | Why? |
| Cyclin D1 | 1 | 2017 | 22 | 0.18 | Why? |
| Low-Level Light Therapy | 1 | 2020 | 129 | 0.18 | Why? |
| Carotid Artery, Common | 1 | 2018 | 49 | 0.18 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 28 | 0.18 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 45 | 0.18 | Why? |
| Monitoring, Intraoperative | 1 | 2019 | 140 | 0.18 | Why? |
| Oligonucleotide Array Sequence Analysis | 2 | 2017 | 343 | 0.17 | Why? |
| Quality of Life | 3 | 2020 | 9820 | 0.17 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 43 | 0.17 | Why? |
| Middle Aged | 34 | 2021 | 270681 | 0.17 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2017 | 77 | 0.17 | Why? |
| Stromal Cells | 1 | 2018 | 105 | 0.17 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 179 | 0.17 | Why? |
| Induction Chemotherapy | 1 | 2018 | 149 | 0.17 | Why? |
| Male | 39 | 2021 | 367725 | 0.17 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.17 | Why? |
| Ligation | 1 | 2017 | 84 | 0.17 | Why? |
| Carotid Artery, Internal | 1 | 2018 | 97 | 0.17 | Why? |
| Pesticides | 1 | 2018 | 100 | 0.17 | Why? |
| Mandible | 1 | 2017 | 72 | 0.17 | Why? |
| Neoplastic Cells, Circulating | 1 | 2017 | 68 | 0.17 | Why? |
| South America | 1 | 2019 | 565 | 0.16 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.16 | Why? |
| Adult | 28 | 2021 | 244371 | 0.16 | Why? |
| Respiratory Muscles | 1 | 2018 | 116 | 0.16 | Why? |
| Tumor Burden | 1 | 2018 | 369 | 0.16 | Why? |
| Female | 38 | 2021 | 380317 | 0.16 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.16 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2017 | 211 | 0.16 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.16 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.15 | Why? |
| Global Burden of Disease | 1 | 2020 | 531 | 0.15 | Why? |
| Protective Devices | 1 | 2020 | 493 | 0.15 | Why? |
| Hypocalcemia | 1 | 2017 | 120 | 0.15 | Why? |
| Lymph Nodes | 1 | 2002 | 1060 | 0.15 | Why? |
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 334 | 0.15 | Why? |
| Blood Loss, Surgical | 1 | 2017 | 211 | 0.15 | Why? |
| Medical Overuse | 1 | 2017 | 146 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Lymph Node Excision | 1 | 2018 | 362 | 0.15 | Why? |
| Surgical Flaps | 1 | 2017 | 188 | 0.15 | Why? |
| DNA, Neoplasm | 1 | 2014 | 56 | 0.14 | Why? |
| Arteries | 1 | 2017 | 283 | 0.14 | Why? |
| Diaphragm | 1 | 2018 | 232 | 0.14 | Why? |
| Cross-Cultural Comparison | 1 | 2017 | 338 | 0.14 | Why? |
| Dentures | 1 | 2013 | 8 | 0.14 | Why? |
| Muscle Weakness | 1 | 2018 | 406 | 0.14 | Why? |
| Oral Health | 1 | 2019 | 401 | 0.14 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.14 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.13 | Why? |
| Africa South of the Sahara | 1 | 2019 | 1335 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Tumor Suppressor Proteins | 1 | 2014 | 165 | 0.13 | Why? |
| Radiopharmaceuticals | 1 | 2018 | 763 | 0.13 | Why? |
| Pandemics | 11 | 2020 | 389249 | 0.12 | Why? |
| Stem Cells | 1 | 2019 | 595 | 0.12 | Why? |
| Gene Expression Profiling | 4 | 2018 | 3788 | 0.12 | Why? |
| Membrane Glycoproteins | 2 | 2019 | 2273 | 0.12 | Why? |
| Oral Ulcer | 1 | 2013 | 70 | 0.12 | Why? |
| Postoperative Care | 1 | 2018 | 755 | 0.12 | Why? |
| Thyroid Gland | 1 | 2017 | 516 | 0.12 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.11 | Why? |
| Asia | 1 | 2019 | 2399 | 0.11 | Why? |
| Smoking Cessation | 1 | 2020 | 826 | 0.11 | Why? |
| Claudins | 1 | 2010 | 22 | 0.11 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2018 | 1153 | 0.11 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Survival Analysis | 3 | 2019 | 7592 | 0.10 | Why? |
| Critical Pathways | 1 | 2020 | 1587 | 0.10 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.10 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.10 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.10 | Why? |
| Tight Junctions | 1 | 2010 | 179 | 0.09 | Why? |
| Survival Rate | 3 | 2017 | 9206 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2018 | 1458 | 0.09 | Why? |
| Reconstructive Surgical Procedures | 1 | 2018 | 860 | 0.09 | Why? |
| Trinucleotide Repeats | 1 | 2007 | 7 | 0.09 | Why? |
| Time Factors | 5 | 2018 | 31397 | 0.09 | Why? |
| Transcriptome | 2 | 2018 | 3466 | 0.08 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.08 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.08 | Why? |
| Resource Allocation | 1 | 2019 | 1771 | 0.08 | Why? |
| Nuclear Proteins | 1 | 2010 | 321 | 0.08 | Why? |
| CpG Islands | 2 | 2019 | 230 | 0.08 | Why? |
| Tracheostomy | 1 | 2020 | 1963 | 0.08 | Why? |
| Cytosine | 1 | 2007 | 92 | 0.08 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.08 | Why? |
| Guanine | 1 | 2007 | 146 | 0.08 | Why? |
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 21 | 0.08 | Why? |
| Proto-Oncogene Proteins c-fos | 1 | 2005 | 50 | 0.08 | Why? |
| Cell Differentiation | 3 | 2019 | 1338 | 0.08 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.07 | Why? |
| Surgeons | 1 | 2020 | 2233 | 0.07 | Why? |
| Transcription Factor AP-1 | 1 | 2005 | 75 | 0.07 | Why? |
| Mitotic Index | 1 | 2004 | 19 | 0.07 | Why? |
| MicroRNAs | 1 | 2018 | 1787 | 0.07 | Why? |
| Health Care Rationing | 1 | 2020 | 2558 | 0.07 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.07 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.07 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.07 | Why? |
| Databases as Topic | 1 | 2005 | 103 | 0.07 | Why? |
| Receptors, Androgen | 1 | 2007 | 212 | 0.07 | Why? |
| Epidemiologic Methods | 2 | 2007 | 392 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.07 | Why? |
| Promoter Regions, Genetic | 2 | 2019 | 823 | 0.07 | Why? |
| Adenine | 1 | 2007 | 463 | 0.07 | Why? |
| Cell Line, Tumor | 3 | 2018 | 3608 | 0.07 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.06 | Why? |
| Risk Assessment | 5 | 2019 | 25439 | 0.06 | Why? |
| Retrospective Studies | 7 | 2018 | 105322 | 0.06 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Models, Theoretical | 1 | 2021 | 6659 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.06 | Why? |
| Prospective Studies | 4 | 2018 | 43301 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Mandibular Reconstruction | 1 | 2020 | 14 | 0.06 | Why? |
| Sex Factors | 2 | 2017 | 11014 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Down-Regulation | 2 | 2018 | 1416 | 0.06 | Why? |
| Dental Prosthesis Design | 1 | 2020 | 26 | 0.05 | Why? |
| Serine Endopeptidases | 1 | 2017 | 4606 | 0.05 | Why? |
| Pathology, Oral | 1 | 2020 | 20 | 0.05 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.05 | Why? |
| Recurrent Laryngeal Nerve | 1 | 2019 | 10 | 0.05 | Why? |
| Neoplasm Metastasis | 2 | 2018 | 682 | 0.05 | Why? |
| Esthetics | 1 | 2020 | 136 | 0.05 | Why? |
| Frozen Sections | 1 | 2018 | 19 | 0.05 | Why? |
| Germ Cells | 1 | 2019 | 39 | 0.05 | Why? |
| Occupational Exposure | 1 | 2018 | 4742 | 0.05 | Why? |
| Atrazine | 1 | 2018 | 4 | 0.05 | Why? |
| Malathion | 1 | 2018 | 3 | 0.05 | Why? |
| Shoulder Pain | 1 | 2019 | 36 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Breast Neoplasms | 1 | 2017 | 3633 | 0.05 | Why? |
| Spectrum Analysis | 1 | 2018 | 112 | 0.05 | Why? |
| Paraffin Embedding | 1 | 2018 | 105 | 0.05 | Why? |
| Linear Models | 1 | 2005 | 1914 | 0.05 | Why? |
| Students, Dental | 1 | 2020 | 210 | 0.05 | Why? |
| Biopsy, Fine-Needle | 1 | 2019 | 274 | 0.05 | Why? |
| Orthodontics | 1 | 2020 | 122 | 0.04 | Why? |
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2017 | 13 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.04 | Why? |
| Spectrometry, Fluorescence | 1 | 2018 | 177 | 0.04 | Why? |
| Tobacco | 1 | 2020 | 274 | 0.04 | Why? |
| Incidence | 4 | 2019 | 25622 | 0.04 | Why? |
| Osteoprotegerin | 1 | 2017 | 32 | 0.04 | Why? |
| Bone Morphogenetic Proteins | 1 | 2017 | 25 | 0.04 | Why? |
| RANK Ligand | 1 | 2017 | 47 | 0.04 | Why? |
| Enhancer Elements, Genetic | 1 | 2017 | 48 | 0.04 | Why? |
| X-Ray Microtomography | 1 | 2017 | 115 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Databases, Bibliographic | 1 | 2018 | 182 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Tobacco Use | 1 | 2020 | 340 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Spectrum Analysis, Raman | 1 | 2018 | 311 | 0.04 | Why? |
| Microarray Analysis | 1 | 2017 | 262 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Genetic Markers | 1 | 2017 | 318 | 0.04 | Why? |
| 3' Untranslated Regions | 1 | 2017 | 318 | 0.04 | Why? |
| Tomography, X-Ray Computed | 1 | 2002 | 25144 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Chromosomes, Human, Pair 22 | 1 | 2014 | 10 | 0.04 | Why? |
| Muscle Strength | 1 | 2018 | 317 | 0.04 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2018 | 9537 | 0.04 | Why? |
| Feeding Behavior | 1 | 2007 | 1909 | 0.03 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.03 | Why? |
| Counseling | 1 | 2020 | 747 | 0.03 | Why? |
| Gene Knockdown Techniques | 1 | 2014 | 347 | 0.03 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.03 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2019 | 1289 | 0.03 | Why? |
| Prevalence | 3 | 2019 | 25773 | 0.03 | Why? |
| Patient Preference | 1 | 2019 | 750 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.03 | Why? |
| Child | 1 | 2020 | 70012 | 0.03 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.03 | Why? |
| Tomography, Optical Coherence | 1 | 2018 | 1008 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Attitude | 1 | 2020 | 1481 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.03 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.02 | Why? |
| Operating Rooms | 1 | 2020 | 1841 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 11367 | 0.02 | Why? |
| Loss of Heterozygosity | 1 | 2007 | 14 | 0.02 | Why? |
| Mutation | 2 | 2019 | 12376 | 0.02 | Why? |
| Models, Statistical | 1 | 2005 | 5312 | 0.02 | Why? |
| Mouth Mucosa | 1 | 2010 | 323 | 0.02 | Why? |
| Microsatellite Instability | 1 | 2007 | 57 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Fos-Related Antigen-2 | 1 | 2005 | 5 | 0.02 | Why? |
| Blotting, Northern | 1 | 2005 | 51 | 0.02 | Why? |
| RNA, Neoplasm | 1 | 2005 | 34 | 0.02 | Why? |
| Registries | 1 | 2005 | 12327 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Transcriptional Activation | 1 | 2005 | 196 | 0.02 | Why? |
| Principal Component Analysis | 1 | 2007 | 689 | 0.02 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Radiotherapy Dosage | 1 | 2005 | 428 | 0.02 | Why? |
| Recurrence | 1 | 2013 | 3675 | 0.02 | Why? |
| Mucous Membrane | 1 | 2005 | 305 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| DNA-Binding Proteins | 1 | 2005 | 469 | 0.01 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.01 | Why? |
| Gene Expression Regulation | 1 | 2014 | 4020 | 0.01 | Why? |
| Alleles | 1 | 2007 | 1557 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Transcription Factors | 1 | 2005 | 784 | 0.01 | Why? |
| Polymorphism, Genetic | 1 | 2007 | 1074 | 0.01 | Why? |
| Alcohol Drinking | 1 | 2007 | 1663 | 0.01 | Why? |
| Multivariate Analysis | 1 | 2005 | 5440 | 0.01 | Why? |
| Life Style | 1 | 2007 | 2708 | 0.01 | Why? |
| Smoking | 1 | 2007 | 3358 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| RNA, Messenger | 1 | 2005 | 5131 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2007 | 17020 | 0.01 | Why? |